New Treatment Strategies in Patients with Advanced Non–Small-Cell Lung Cancer and Performance Status 2

2008 ◽  
Vol 9 (6) ◽  
pp. 326-330 ◽  
Author(s):  
Estelamari Rodriguez ◽  
Rogerio C. Lilenbaum
Open Medicine ◽  
2014 ◽  
Vol 9 (3) ◽  
pp. 382-390
Author(s):  
Diana Schveigert ◽  
Saulius Cicenas ◽  
Jaroslav Bublevic ◽  
Renatas Askinis ◽  
Virginijus Sapoka ◽  
...  

AbstractThe development of non-small-cell lung cancer (NSCLC) is a multistep process, which is triggered and maintained by various factors. Many steps of non-small-cell lung carcinogenesis, risk factors and biomarkers have been identified; however no consistent model has been established of personalized medicine for these patients. Distinct various gene expression, products of mutated genes and other markers such as circulating nucleic acids or tumor cells has been proven to be potential biomarkers of non-small cell lung cancer as well as potential targets for new treatment strategies. This article will highlight promising biomarkers in non-small cell lung cancer prognosis.


Lung Cancer ◽  
2012 ◽  
Vol 75 ◽  
pp. S52
Author(s):  
E. Larbi ◽  
G. Middleton ◽  
T. Partridge-James ◽  
S. Quirin ◽  
V. Hardacre ◽  
...  

2020 ◽  
Vol 21 (5) ◽  
pp. e388-e404
Author(s):  
Rebekah Rittberg ◽  
Susan Green ◽  
Trevor Aquin ◽  
Oliver Bucher ◽  
Shantanu Banerji ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document